Eko Health vs Veeva Systems
Side-by-side comparison of AI visibility scores, market position, and capabilities
Eko Health has sold 700,000+ digital stethoscopes with FDA-cleared AI for murmur, AFib, and low ejection fraction detection; AMA granted a Category III CPT code for its Sensora AI platform in 2025.
About
Eko Health is a medical technology company that has reimagined the stethoscope by integrating digital amplification, ECG capture, and artificial intelligence into a clinical-grade device for heart and lung auscultation. Its flagship product, the CORE 500™ digital stethoscope, features 40x sound amplification, active noise cancellation, a 3-lead ECG, a full-color display, and FDA-cleared AI algorithms for detecting heart murmurs, atrial fibrillation (AFib), and low left ventricular ejection fraction (LVEF) — a key indicator of developing heart failure. Eko has sold more than 700,000 stethoscopes worldwide, establishing broad clinical adoption ahead of any direct competitor.
Veeva Systems (VEEV) reported $2.7B revenue in FY2025, up 14% YoY. #1 cloud platform for life sciences. ~8,000 employees. HQ: Pleasanton, CA. Market cap ~$40B.
About
Veeva Systems Inc. is the leading cloud software provider for the global life sciences industry, headquartered in Pleasanton, California. Founded in 2007 by Peter Gassner (a former Salesforce executive) and Matt Wallach, Veeva built its platform on Salesforce and later developed its own Vault cloud infrastructure. The company became a public benefit corporation (PBC) in 2021. Veeva reported revenues of $2.7B in fiscal year 2025 (ending January 2025), up 14% year-over-year, with a market capitalization of approximately $40B.
Key Details
Capabilities & Ecosystem
Capabilities
Integrations
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.